Accumulated SET protein up-regulates and interacts with hnRNPK, increasing its binding to nucleic acids, the Bcl-xS repression, and cellular proliferation

Biochemical and Biophysical Research Communications

Volumn 445, Issue 1, 2014, Pages 196-202

  Almeida, Luciana O ^a   Garcia, Cristiana B ^a   Matos Silva, Flavia A ^a   Curti, Carlos ^a   Leopoldino, Andréia M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alternative splicing; Bcl xS; hnRNPK; HNSCC; Interaction DNA protein; SET; SET hnRNPK

Indexed keywords

BCL XS PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; MESSENGER RNA; NUCLEIC ACID; PHOSPHOPROTEIN; PROTEIN; PROTEIN BCL X; TAF 1BETA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL STRAIN HEK293; CELL STRAIN HN12; CELL STRAIN HN13; CELL STRAIN HN6; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN REPRESSION; UPREGULATION;

ALTERNATIVE SPLICING; BCL-XS; HNRNPK; HNSCC; INTERACTION DNA-PROTEIN; SET; SET-HNRNPK;

BCL-X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HEAD AND NECK NEOPLASMS; HEK293 CELLS; HISTONE CHAPERONES; HUMANS; IMMUNOBLOTTING; MICROSCOPY, CONFOCAL; NUCLEIC ACIDS; PHOSPHORYLATION; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEOPROTEINS; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84896733638     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.175     Document Type: Article

References (30)

1. K. Bomsztyk, O. Denisenko, and J. Ostrowski HnRNPK: one protein multiple processes BioEssays 26 2004 629 638
2. E.F. Michelotti, G.A. Michelotti, A.I. Aronsohn, and D. Levens Heterogeneous nuclear ribonucleoprotein K is a transcription factor Mol. Cell. Biol. 16 1996 2350 2360
3. K. Bomsztyk, I. Van Seuningen, H. Suzuki, O. Denisenko, and J. Ostrowski Diverse molecular interactions of the hnRNPK protein FEBS Lett. 403 1997 113 115
4. H. Habelhah, K. Shah, L. Huang, A. Ostareck-Lederer, A.L. Burlingame, K.M. Shokat, M.W. Hentze, and Z. Ronai ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation Nat. Cell Biol. 3 2001 325 330
5. K.W. Hsueh, S.L. Fu, C.Y. Huang, and C.H. Lin Aurora-A phosphorylates hnRNPK and disrupts its interaction with p53 FEBS Lett. 585 2011 2671 2675
6. M. Takimoto, T. Tomonaga, M. Matunis, M. Avigan, H. Krutzsch, G. Dreyfuss, and D. Levens Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro J. Biol. Chem. 268 1993 18249 18258
7. A. Moumen, P. Masterson, M.J. O'Connor, and S.P. Jackson HnRNPK: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage Cell 123 2005 1065 1078
8. T. Revil, J. Pelletier, J. Toutant, A. Cloutier, and B. Chabot Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform J. Biol. Chem. 284 2009 21458 21467
9. Y. Chen, Y.N. Wang, and H.H. Zhou Progress in the study of heterogeneous nuclear ribonucleoprotein and its relation with diseases Sheng Li Ke Xue Jin Zhan 39 2008 109 113
10. I. Pino, R. Pio, G. Toledo, N. Zabalegui, S. Vicent, N. Rey, M.D. Lozano, W. Torre, J. Garcia-Foncillas, and L.M. Montuenga Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer Lung Cancer 41 2003 131 143
11. P. Roychoudhury, and K. Chaudhuri Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma Br. J. Cancer 97 2007 574 575 (author reply 576)
12. B. Carpenter, M. McKay, S.R. Dundas, L.C. Lawrie, C. Telfer, and G.I. Murray Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer Br. J. Cancer 95 2006 921 927
13. M. Mikula, P. Gaj, K. Dzwonek, T. Rubel, J. Karczmarski, A. Paziewska, A. Dzwonek, P. Bragoszewski, M. Dadlez, and J. Ostrowski Comprehensive analysis of the palindromic motif TCTCGCGAGA: a regulatory element of the HNRNPK promoter DNA Res. 17 2010 245 260
14. A. Matta, S.C. Tripathi, L.V. DeSouza, J. Grigull, J. Kaur, S.S. Chauhan, A. Srivastava, A. Thakar, N.K. Shukla, R. Duggal, S. DattaGupta, R. Ralhan, and K.W. Michael Siu Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma Int. J. Cancer 125 2009 1398 1406
15. P. Neviani, R. Santhanam, R. Trotta, M. Notari, B.W. Blaser, S. Liu, H. Mao, J.S. Chang, A. Galietta, A. Uttam, D.C. Roy, M. Valtieri, R. Bruner-Klisovic, M.A. Caligiuri, C.D. Bloomfield, G. Marcucci, and D. Perrotti The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein Cancer Cell 8 2005 355 368
16. Z. Karetsou, A. Emmanouilidou, I. Sanidas, S. Liokatis, E. Nikolakaki, A.S. Politou, and T. Papamarcaki Identification of distinct SET/TAF-Ibeta domains required for core histone binding and quantitative characterisation of the interaction BMC Biochem. 10 2009 10
17. J.M. Estanyol, M. Jaumot, O. Casanovas, A. Rodriguez-Vilarrupla, N. Agell, and O. Bachs The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity J. Biol. Chem. 274 1999 33161 33165
18. N. Canela, A. Rodriguez-Vilarrupla, J.M. Estanyol, C. Diaz, M.J. Pujol, N. Agell, and O. Bachs The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity J. Biol. Chem. 278 2003 1158 1164
19. J. Vera, M. Jaumot, J.M. Estanyol, S. Brun, N. Agell, and O. Bachs Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor Oncogene 25 2006 260 270
20. A.M. Leopoldino, C.H. Squarize, C.B. Garcia, L.O. Almeida, C.R. Pestana, L.M. Sobral, S.A. Uyemura, E.H. Tajara, J. Silvio Gutkind, and C. Curti SET protein accumulates in HNSCC and contributes to cell survival: antioxidant defense, Akt phosphorylation and AVOs acidification Oral Oncol. 48 2012 1106 1113
21. L.O. Almeida, R.N. Goto, C.R. Pestana, S.A. Uyemura, S. Gutkind, C. Curti, and A.M. Leopoldino SET overexpression decreases cell detoxification efficiency: ALDH2 and GSTP1 are downregulated, DDR is impaired and DNA damage accumulates FEBS J. 279 2012 4615 4628
22. R. Zhou, R. Shanas, M.A. Nelson, A. Bhattacharyya, and J. Shi Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53 Int. J. Cancer 126 2010 395 404
23. A. Ostareck-Lederer, D.H. Ostareck, C. Cans, G. Neubauer, K. Bomsztyk, G. Superti-Furga, and M.W. Hentze C-Src-mediated phosphorylation of hnRNPK drives translational activation of specifically silenced mRNAs Mol. Cell. Biol. 22 2002 4535 4543
24. N.C. Kwiek, D.F. Thacker, M.B. Datto, H.B. Megosh, and T.A. Haystead PITK, a PP1 targeting subunit that modulates the phosphorylation of the transcriptional regulator hnRNPK Cell. Signal. 18 2006 1769 1778
25. T. Iwasaki, Y. Koretomo, T. Fukuda, M.P. Paronetto, C. Sette, Y. Fukami, and K. Sato Expression, phosphorylation, and mRNA-binding of heterogeneous nuclear ribonucleoprotein K in Xenopus oocytes, eggs, and early embryos Dev. Growth Differ. 50 2008 23 40
26. L.C. Chen, H.P. Liu, H.P. Li, C. Hsueh, J.S. Yu, C.L. Liang, and Y.S. Chang Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNPK in nasopharyngeal carcinoma cells Oncogene 28 2009 1904 1915
27. C. Naro, and C. Sette Phosphorylation-mediated regulation of alternative splicing in cancer Int. J. Cell Biol. 2013 2013 151839
28. T.S. Ro-Choi, and Y.C. Choi Thermodynamic analyses of the constitutive splicing pathway for ovomucoid pre-mRNA Mol. Cells 27 2009 657 665
29. M. Lynch, L. Chen, M.J. Ravitz, S. Mehtani, K. Korenblat, M.J. Pazin, and E.V. Schmidt HnRNPK binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation Mol. Cell. Biol. 25 2005 6436 6453
30. J. Lee, J. Zhou, X. Zheng, S. Cho, H. Moon, T.J. Loh, K. Jo, and H. Shen Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA Biochem. Biophys. Res. Commun. 420 2012 467 472